Recalls / Active ingredient / Insulin Degludec
Insulin Degludec
4 FDA drug recalls involving the active ingredient “Insulin Degludec” — 4 Class I.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2021-03-22 | Class I | TRESIBA (insulin degludec injection) 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, | Novo Nordisk Inc |
| 2021-03-22 | Class I | TRESIBA FlexTouch (insulin degludec injection) 100 units/mL (U-100), 3 mL Prefilled Pen, Sample, Rx only, Man | Novo Nordisk Inc |
| 2021-03-22 | Class I | TRESIBA FlexTouch (insulin degludec injection) 200 units/mL (U-200), 3 mL Prefilled Pen, Sample, Rx only, Manu | Novo Nordisk Inc |
| 2021-03-22 | Class I | Xultophy 100/3.6 (insulin degludec and liraglutide injection), 100 units/mL and 3.6 mg/mL, 3 mL Prefilled Pen, | Novo Nordisk Inc |